₹-0.59
(Market cap
₹28 Cr
Recently Viewed
Clear AllMarket cap
₹28 Cr
Revenue (TTM)
₹82 Cr
P/E Ratio
12.4
P/B Ratio
0.3
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹2 Cr
ROE
1.2 %
ROCE
1.7 %
Industry P/E
30.09
EV/EBITDA
5.9
Debt to Equity
0
Book Value
₹44.4
EPS
₹0.9
Face value
10
Shares outstanding
24,749,180
CFO
₹-6.64 Cr
EBITDA
₹75.01 Cr
Net Profit
₹56.20 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Deccan Health Care
| -23.0 | 4.6 | -18.2 | -42.3 | -26.7 | -17.6 | -- |
|
BSE Healthcare
| 1.8 | 4.5 | 5.7 | 4.6 | 24.6 | 13.6 | 11.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Deccan Health Care
| -50.8 | -7.2 | -22.6 | 51.5 | -16.3 | -55.7 | -34.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Deccan Health Care
|
11.4 | 28.2 | 81.7 | 2.3 | 4.1 | 2.1 | 12.4 | 0.3 |
| 2,780.8 | 34,720.9 | 5,201.6 | 1,014.6 | 22.9 | 25 | 34.2 | 7.6 | |
| 8,456.5 | 21,146.3 | 2,177.5 | 200.9 | 11.3 | 26.5 | 105.3 | 25.4 | |
| 1,768.0 | 13,483.3 | 2,089.5 | 622.0 | 31.3 | 20.4 | 22 | 4.1 | |
| 1,644.5 | 10,030.3 | 1,196.4 | 149.4 | -- | 27.5 | 67.1 | 14.3 | |
| 1,395.7 | 19,442.4 | 3,078.2 | 469.4 | 26.4 | 14.9 | 45 | 5.4 | |
| 2,011.5 | 32,315.7 | 4,193.0 | 753.8 | 22.7 | 20.8 | 42.9 | 8.1 | |
| 4,783.2 | 21,920.9 | 2,482.3 | 853.6 | 33.7 | 18.9 | 25.7 | 5.5 | |
| 5,205.9 | 8,626.2 | 1,348.5 | 293.5 | 28.1 | 50.7 | 29.4 | 12.4 | |
| 1,069.0 | 9,870.8 | 4,725.6 | 528.7 | 14.9 | 20.7 | 19.3 | 3.3 |
No Review & Analysis are available.
Manufacture of pharmaceuticals, medicinal chemical and botanical products
Incorporated
1996
Chairman
--
Managing Director
Minto Gupta
Headquarters
Hyderabad, Telangana
Website
Looking for more details about Deccan Health Care Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Deccan Health Care Ltd is ₹11.40 (BSE) as of 23-Apr-2026 IST. Deccan Health Care Ltd has given a return of -26.75% in the last 3 years.
The P/E ratio of Deccan Health Care Ltd is 12.39 times as on 23-Apr-2026, a 59 discount to its peers’ median range of 30.09 times.
The P/B ratio of Deccan Health Care Ltd is 0.26 times as on 23-Apr-2026, a 94 discount to its peers’ median range of 4.67 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
34.25
|
0.38
|
|
2024
|
37.71
|
0.59
|
|
2023
|
153.12
|
0.57
|
|
2022
|
174.14
|
0.73
|
|
2021
|
118.49
|
0.60
|
The 52-week high and low of Deccan Health Care Ltd are Rs 24.40 and Rs 6.65 as of 23-Apr-2026.
Deccan Health Care Ltd has a market capitalisation of ₹ 28 Cr as on 23-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Deccan Health Care Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.